Sonova Holding (OTCMKTS:SONVY) Short Interest Update

Sonova Holding (OTCMKTS:SONVY) was the recipient of a large increase in short interest in July. As of July 15th, there was short interest totaling 1,508 shares, an increase of 75.8% from the June 30th total of 858 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 36,640 shares, the days-to-cover ratio is currently 0.0 days.

Analysts Set New Price Targets

SONVY has been the topic of several recent research reports. UBS Group upgraded Sonova from a “hold” rating to a “buy” rating in a research report on Wednesday, July 22nd. Citigroup reiterated a “sell” rating on shares of Sonova in a report on Friday, July 24th. Finally, Morgan Stanley upgraded shares of Sonova from an “underweight” rating to an “equal weight” rating in a report on Tuesday, June 23rd. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold”.

Sonova Stock Down 0.3%

SONVY stock traded down $0.17 on Thursday, reaching $54.30. 4,050 shares of the company traded hands, compared to its average volume of 34,342. The firm has a fifty day simple moving average of $50.70 and a 200-day simple moving average of $49.72. The company has a quick ratio of 1.43, a current ratio of 1.75 and a debt-to-equity ratio of 0.51. Sonova has a one year low of $42.26 and a one year high of $61.09.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.